Who was studied, and how
Nine numbers in the abstract
Where each one falls
Where it lands on the map
732people with hypertension, in this paper
Already taking statin [+] group, or nottheir own situation, not assigned
on statin [+] group
statin [-] group
Statin [+] group went with higher BP control+14.0
correlation, not a testthe abstract, start to end
… [-] group: 73 vs 64% respectively (+14%, P < 0.05).
… (n = 93), or triple therapy (n = 18): -38.8/-20.0, -39.1/-20.1, -38.0/-19.4, -39.9/-18.3 mmHg respectively (P < 0.001 vs …
← favours treatmentfavours comparator →
could be chanceNo interval given · direction only, strength unknown
BP control (<140/90 mmHg)statin [+] group vs statin [-] group, in patients with concomitant hypertension and hypercholesterolemia
14
BP reduction (systolic/diastolic)perindopril/amlodipine vs baseline, in statin [+] group, previously untreated (n = 18)
−38.8
BP reduction (systolic/diastolic)perindopril/amlodipine vs baseline, in statin [+] group, previously untreated (n = 18)
−20.0
BP reduction (systolic/diastolic)perindopril/amlodipine vs baseline, in statin [+] group, treated with monotherapy (n = 97)
−39.1
BP reduction (systolic/diastolic)perindopril/amlodipine vs baseline, in statin [+] group, treated with monotherapy (n = 97)
−20.1
BP reduction (systolic/diastolic)perindopril/amlodipine vs baseline, in statin [+] group, treated with dual therapy (n = 93)
−38.0
BP reduction (systolic/diastolic)perindopril/amlodipine vs baseline, in statin [+] group, treated with dual therapy (n = 93)
−19.4
BP reduction (systolic/diastolic)perindopril/amlodipine vs baseline, in statin [+] group, treated with triple therapy (n = 18)
−39.9
BP reduction (systolic/diastolic)perindopril/amlodipine vs baseline, in statin [+] group, treated with triple therapy (n = 18)
−18.3
StatinsAntihypertensivesBlood pressure
1 / 4